Proposed Nasdaq symbol ELYM. Business: Phase 2a biotech developing therapies for neuronal excitablility disorders. FinWise Bancorp - Murray, Utah, ...
News
- Initial public offerings scheduled to debut next week
- Oncolytics Biotech Inc. (ONCY) CEO Matt Coffey on Q2 2021 Results - Earnings Call Transcript
But you know, for San Antonio, it'll definitely be a safety updates. We'll see what we can negotiate in terms of additional information. Patrick Trucchio.
- Machine learning plus insights from genetic research shows the workings of cells - and may help ...
... technique that allows biomedical researchers to figure out the functions of the proteins that turn genes on and off in cells, called transcription factors.
- Twist Bioscience: Fiscal Q3 Earnings Snapshot
The maker of synthetic DNA for the biotechnology industry posted revenue of $35 million in the period, beating Street forecasts. Five analysts surveyed ...
- Report: Uranium cleanup could benefit New Mexico, tribes
... state Economic Development Department and New Mexico Bioscience Authority, asking that they look into what it would take to create this industry, ...